1. Home
  2. Live Updates
  3. Medscape coronavirus resource center

Live Breaking News & Updates on Medscape coronavirus resource center

Stay informed with the latest breaking news from Medscape coronavirus resource center on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Medscape coronavirus resource center and stay connected to the pulse of your community

No Increase in MS Disease Activity Due to COVID-19

COVID-19 has no impact on disease activity, progression, or cognitive performance in patients with multiple sclerosis.

Italy , Milan , Lombardia , Fondazione-italiana-sclerosi-multipla , Federico-montini , Medscape-coronavirus-resource-center , Coronavirus-resource , Expanded-disability-status-scale , Modified-fatigue-impact-scale , Hospital-anxiety , Depression-scale , Pittsburgh-sleep-quality-index

Elderly Patients at Highest Risk for Severe COVID Outcomes

Among Canadians, patients aged 80 years or older are the least likely to have a history of COVID-19 infection and the most likely to be hospitalized or die following infection, data indicate.

Vancouver , British-columbia , Canada , United-kingdom , British , Canadian , Canadians , Danutam-skowronski , Bonnie-henry , Zain-chagla , Romina-reyes , Pfizer

How to Boost COVID Vaccination Rates in Pregnant Women

Physicians provided tips on how to increase rates of pregnant women receiving the COVID-19 booster.

Dover , New-hampshire , United-states , Nassau , New-providence , Bahamas , The , New-york , Aaron-glatt , Janet-perkins , Camille-clare , American-college-of-obstetricians

mRNA Vaccine Cuts COVID-Related Guillain-Barré Risk

COVID-19 increases the risk for Guillain-Barré syndrome sixfold, while getting the Pfizer mRNA vaccine lowers risk.

Arbel , Ha-afon , Israel , Haya-bishara , Eitan-auriel , Medscape-coronavirus-resource-center , Lady-davis-carmel-medical-center , Boehringer-ingelheim , Pfizer , Israel-institute-of-technology , Novo-nordisk , Coronavirus-resource

Paxlovid Tied to Benefits in High-Risk Patients With COVID

The use of nirmatrelvir–ritonavir (Paxlovid) is associated with a lower risk for death or hospitalization in extremely vulnerable patients with COVID-19. Low-risk patients do not appear to benefit.

United-kingdom , Canada , Vancouver , British-columbia , Ohio , United-states , British , Colinr-dormuth , University-of-british-columbia , British-columbia-ministry-of-health , Medscape-coronavirus-resource-center

Shortages, Cost, and Frustration: Quest for the New COVID Shot

As the rollout of the newly formulated shot begins in earnest, many Americans are finding roadblocks.

New-jersey , United-states , New-york , Pennsylvania , Americans , American , Mandy-cohen , Matt-blanchette , Xavier-becerra , Dotty-johnson , Levi-shaw-faber , Dana-tofig

Pneumonia, Not Just Inflammation, May Cause Severe COVID

New research from Northwestern University and the University of Wisconsin, however, is pointing to bacterial pneumonia as the cause of many severe COVID deaths.

Northwestern-university , Illinois , United-states , New-york , Chicago , India , Italy , Italian , Jonas-schluter , University-of-wisconsin , Institute-for-systems-genetics , Medscape-coronavirus-resource-center

Paxlovid Weaker Against Current COVID-19 Variants

A real-world study found that Pfizer's COVID-19 antiviral Paxlovid is now less effective at preventing hospitalization or death in high-risk patients as compared with earlier studies.

Cleveland-clinic , Florida , United-states , Bloomberg , Medscape-coronavirus-resource-center , Coronavirus-resource , North-carolina-gillings-school , Global-public-health , Molnupiravir-use , Severe-outcomes-from-omicron-infections , First-oral-antiviral

Paxlovid, Lagevrio Benefit COVID Outpatients in Omicron Era

The American College of Physicians has issued an updated version of its living, rapid practice point guideline on the best treatment options for outpatients with confirmed COVID-19.

Philadelphia , Pennsylvania , United-states , Oregon , New-york , Portland , America , Amir-qaseem , Mirella-salvatore , Lindal-humphrey , Population-health , Oregon-health

SGLT2-inhibitors: No Benefit in Hospitalized COVID-19

However, an important take-home message from this new meta-analysis is that these widely used medications appeared to be safe even in acutely ill hospitalized patients, the researchers say.

Missouri , United-states , Massachusetts , Netherlands , Boston , Amsterdam , Noord-holland , Mikhail-kosiborod , Muthiah-vaduganathan , Medscape-coronavirus-resource-center , World-health-organization , European-society-of-cardiology